| 000 | 01518 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250511223443.0 | ||
| 264 | 0 | _c19910118 | |
| 008 | 199101s 0 0 eng d | ||
| 022 | _a0732-6580 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAbbruzzese, J L | |
| 245 | 0 | 0 |
_aA phase II trial of recombinant human interferon-gamma and recombinant tumor necrosis factor in patients with advanced gastrointestinal malignancies: results of a trial terminated by excessive toxicity. _h[electronic resource] |
| 260 |
_bJournal of biological response modifiers _cOct 1990 |
||
| 300 |
_a522-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 | _aDrug Evaluation |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGastrointestinal Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterferon-gamma _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aRecombinant Proteins _xadministration & dosage |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xadministration & dosage |
| 700 | 1 | _aLevin, B | |
| 700 | 1 | _aAjani, J A | |
| 700 | 1 | _aFaintuch, J S | |
| 700 | 1 | _aPazdur, R | |
| 700 | 1 | _aSaks, S | |
| 700 | 1 | _aEdwards, C | |
| 700 | 1 | _aGutterman, J U | |
| 773 | 0 |
_tJournal of biological response modifiers _gvol. 9 _gno. 5 _gp. 522-7 |
|
| 999 |
_c2130070 _d2130070 |
||